Tracing Oncogene Rearrangements in the Mutational History of Lung Adenocarcinoma

Lee, Jake June-Koo, Park, Seongyeol, Park, Hansol, Kim, Sehui, Lee, Jongkeun, Lee, Junehawk, Youk, Jeonghwan, Yi, Kijong, An, Yohan, Park, In Kyu, Kang, Chang Hyun, Chung, Doo Hyun, Kim, Tae Min, Jeon, Yoon Kyung, Hong, Dongwan, Park, Peter J., Ju, Young Seok, Kim, Young Tae·2019·Cell
DOI 10.1016/j.cell.2019.05.013

Cited by (207)

Items 201–207 of 207

  1. Clastogenesis by nucleotide lesions requires the completion of two cell cycles
    Jacob G. Jansen, Piya Temviriyanukul, Daniel C. de Groot, Karoly Szuhai, Sandrine van Hees-Stuivenberg, Anastasia Tsaalbi-Shtylik, Heinz Jacobs, Niels de Wind · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  2. Epithelial plasticity in lung cancer evolution: insights from organoids
    Sungji Moon, Dakyung Lee, Jaeyong Choi, Seyoon Lee, Jong‐Il Kim · 2026 · Organoid
  3. Etudes des translocations chromosomiques en utilisant les méthodes d'édition du génome : des mécanismes moléculaires à l’oncogenèse
    Loélia Babin · 2019 · theses.fr (ABES)
  4. Rôles des mutations somatiques dans STAG2, TP53 et CDKN2A et de la chromoplexie dans l'oncogenèse du sarcome d'Ewing
    Maxime Heintzé · 2024 · theses.fr (ABES)
  5. Targeting AVEN Liquid‐Liquid Phase Separation in Colorectal Cancer: Insights From a Raddeanin A‐Based Chemical Probe
    Xichao Yu, Hui Wu, Kezhen Guo, Zihao Liu, Lianxin Zhou, Hongjie Wu, Shuyuan Wang, Jiaqi Fu, Xing Cui, Zhifei Fu et al. · 2026 · Basic & Clinical Pharmacology & Toxicology
  6. RanBP2 promotes ferroptosis resistance and compromises therapeutic response by stabilizing SLC7A1 through LRSAM1 SUMOylation and ubiquitination in lung adenocarcinoma
    Shiwei Guo, Yu Zeng, Qinfen Zhang, Xiaohe Zhao, Haixia Jin, Baihui Li, Meng Shen, Qing Yang, Lili Yang · 2026 · Cell Death and Differentiation
  7. Unraveling the lexicon of complex mutational phenomena in human cancers
    Ting Yang, Erik N. Bergstrom, Stanley Clarke, Marcin B. Imielinski, Ludmil B. Alexandrov · 2026 · Nature Cancer